XT
DAWN

XTX Topco’s Day One Biopharmaceuticals DAWN Stock Holding History

XTX Topco’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-128,440
Closed -$1.2M – 3931
2025
Q4 		$1.2M Buy
128,440
+49,592
+63% +$414K 0.03% 900
2025
Q3 		$556K Buy
78,848
+54,580
+225% +$376K 0.03% 989
2025
Q2 		$158K Buy
+24,268
New +$167K 0.01% 1773
2024
Q4 		– Sell
-12,778
Closed -$178K – 2409
2024
Q3 		$178K Buy
+12,778
New +$182K 0.01% 1483
2024
Q2 		– Sell
-24,042
Closed -$397K – 1985
2024
Q1 		$397K Buy
+24,042
New +$360K 0.05% 625
2023
Q3 		– Sell
-17,049
Closed -$204K – 1647
2023
Q2 		$204K Sell
17,049
-3,533
-17% -$46.1K 0.04% 993
2023
Q1 		$275K Buy
+20,582
New +$402K 0.06% 723

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

XTX Topco's DAWN Position: Q1 2026 in Review

XTX Topco sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 128,440 shares — an estimated $1.2M sold.

XTX Topco first reported a position in DAWN in Q1 2023 and held it in 7 quarters. The position peaked at $1.2M in Q4 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • XTX Topco reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 128,440 Day One Biopharmaceuticals shares in Q1 2026, an estimated $1.2M.
  • XTX Topco first reported a position in Day One Biopharmaceuticals in Q1 2023 and held it in 7 quarters.
  • XTX Topco's Day One Biopharmaceuticals position peaked at $1.2M in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.